Evidence map›Paper›PMID 40848215›Full record

ArticleJournal of clinical monitoring and computing2026

Improved efficiency of the new Mirus™ system challenged by ventilatory settings-a bench study.

Frederic Albrecht, Claudia Schirra, Kathrin Scheffler, Thomas Volk, Andreas Meiser

Abstract read
In one paragraph

Article in Journal of clinical monitoring and computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frederic AlbrechtDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany. Frederic.Albrecht@uks.eu.
Claudia SchirraDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
Kathrin SchefflerDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
Thomas VolkDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
Andreas MeiserDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Mirus™ system (Technologie Institut Medizin GmbH, Germany) enables target-controlled delivery of volatile anaesthetics with open system ventilators. Its interface, positioned between Y-piece and the patient, injects anaesthetic vapor during inspiration, while adsorbing anaesthetic and resupplying it during the next inspiration. A newly introduced interface (Lisa-44) was evaluated under body temperature pressure saturated and normocapnic conditions using a test lung. Volume-controlled ventilation was applied with a 500 mL tidal volume, 10 bpm respiratory rate, and inspiratory flow (IF) times of 2.5 s and 0.5 s. Isoflurane (sevoflurane) target concentrations were stepwise increased to 1.5 MAC and then decreased. An external gas monitor recorded real-time anaesthetic concentrations. End-tidal concentrations (EC) and area under the curve (AUC) were analyzed for each breath. Accuracy and precision were assessed using Bland-Altman plots. Consumption was calculated and compared to historical controls. Mirus EC measurements correlated well with external gas monitor readings. ECs fluctuated around targets, with higher targets requiring more frequent injections and larger AUCs. Anaesthetic consumption was lower than historical controls and comparable to the Sedaconda ACD. At 0.3-0.5 MAC, hourly isoflurane consumption ranged from 1.0 to 1.7 mL (sevoflurane: 3.8-6.1 mL). However, very short IF times significantly increased consumption, reaching 43 mL sevoflurane at an EC of 2.6 vol%, with prolonged injections extending into the expiration phase. The new system demonstrates high accuracy, precision, and improved efficiency, suggesting reduced anaesthetic consumption in clinical use. However, high concentrations combined with very short IF times substantially increase consumption, indicating potential limitations.

Indexed as

Anesthesia, InhalationAnesthetics, InhalationRespiration, ArtificialVentilators, MechanicalArea Under CurveEquipment DesignHumansIsofluraneMethyl EthersReproducibility of ResultsSevofluraneTidal VolumeAnesthetics, InhalationIsofluraneMethyl EthersSevofluraneInhaled sedationIsofluraneMirusSevofluraneVolatile anaesthetics

Identifiers

PMID40848215
PMCPMC12963147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.